首页> 外文期刊>Seminars in cancer biology >DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death.
【24h】

DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death.

机译:DAP激酶是与加速细胞死亡相关的癌症和疾病中药物设计的目标。

获取原文
获取原文并翻译 | 示例
           

摘要

Misregulated cell death, which can result in either the excessive, inappropriate elimination of cells, or in the insufficient removal of damaged or malignant cells, has been associated with numerous diseases. Here we discuss an important molecular regulator of cell death, DAP-kinase (DAPk), which presents a promising target for therapeutic intervention. A structure-functional analysis of this calcium-regulated Ser/Thr kinase which promotes cell death will be presented, and emphasis will be placed on particular disease models in which its modulation might affect clinically-relevant cell death processes.
机译:错误的细胞死亡可能导致过多,不适当的细胞清除,或者导致受损或恶性细胞的清除不充分,与许多疾病有关。在这里,我们讨论细胞死亡的重要分子调节剂DAP激酶(DAPk),它为治疗干预提出了有希望的目标。将介绍这种钙调节的Ser / Thr激酶促进细胞死亡的结构功能分析,并将重点放在其调节可能影响临床相关细胞死亡过程的特定疾病模型上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号